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There W:IS a significant (p<O.(X)Ol) linear correl:~tion o f GI-IBP S D score with IGF-I concentration (r=+0.2$) and rne:ln 1211 G H concentration (r=-1).17). CONCLUSIONS: ISS oaticnts will] low GtIUI' levels. colno:lred with those with nomlal GIIBP levels, Gad lower IGF-I levels xnd higher &an 12h GH levels, suggesting parti;ll C H insensitivity; Ilowever, the two groups had similar height SD scores :~nd first year respor~se 10 GI1 thcr;ipy. Ueing a s e n s i t i v e DELPHIA (time-resolved fluoraimmunoassay) f o r measurement o f LH, w e have reanalyzed 250 spontaneous s e c r e t o r y s t u d i e s . Samples were obtained every 20 mlniites and a l i q u o t a from timed i n t e r v a l s were pooled: 24HR = 0800-0800h, AN = 0800-1600h, PH = 2200-0600h. Pools were aseayed f o r LH ( a c n o i t i v i t y 0.0365 IU/L); and FSH, CH, testosterone ( T ) , and e s t r a d i o l (EZ) were measured by radioimmunoaseay.
I n 89 c o n t r o l males, t h e r e wae a r i a e i n 24HR LH a t p u b e r t a l s t a g e (PS) I 1 (3.4713.97) over PS I (0.55r0.69, p<0.001), with a decrease again i n PS 111 (1.4610.38). This p a t t e r n was not seen i n t h e 51 c o n t r o l females. I n t h e 85 pubertal c o n t r o l s . t h e r e was a d i u r n a l v a r i a t i o n with PH LH 13.92~3.781 hraher than AN LH 11.79t1.65, o<0.011. There was a weak correlation of-24HR LH w i t h 2 4~~ GH ( r = d . i 4 , p<0'.02) and s t r o n g e r c o r r e l a t i o n s with 24HR FSH ( r = 0 . 5 6 ) , 24HR EZ (rz0.371, and 24HR T (r-0.35). I n t e e e e t i n g l y , c r a n i a l l y i r r a d~a t e d PS I c h i l d r e n ( n = 12) had higher 24HR LH (3.32+6.00) compared t o 66 PS I c o n t r o l e (0.62r0.85, p<0.001) and FSH (13.25i18.02 vs 2.03r1.78, p<0.001), whereas t h e i r mean T and E2 where not d r f f e r e n t .
Pooled LH values are ueeful a d d i t i o n s t o spontanoue s e c r e t i o n s t u d i e s and g i v e information on p u b e r t a l changes, d i u r n a l v a r~a t i o n , and e a r l y puberty i n c r a n i a l i r r a d i a t i o n . 
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ANALYSIS OF GROWTH HORMONE SECRETORY DEFICIENCY
Growth hormono (GH) s e c r e t o r y reaponees t o provocative s t i m u l a t i o n t e s t s are o f t e n blunted i n s h o r t s t a t u r e d c h i l d r e n . The o b j e c t i v e of t h e p r e s e n t study was t o e v a l u a t e v a r i o u s p i t u i t a r y f a c t o r s t h a t may c o n t r i b u t e t o low GH s e c r e t i o n u s i n g rodent models t h a t are hyporeeponaive t o GH secretagogues. Plaema GH c o n c e n t r a t i o n s d i d not
i n c r e a a e above b a s a l v a l u e s (1.7 t 0.7 v s 316 * 89.9 ng/ml) a f t e r GHRH and/or GHRP a d m i n i s t r a t i o n i n mice l a c k i n g p i t u i t a r y r e c e p t o r s f o r GH. Plasma GH increased i n dwarf r a t s with d e f e c t i v e cAHP second meesenger systeme; however, c o n c e n t r a t i o n s were lower t h a n normal (67 + 3 ng/ml v s 1396 t 76 ng/ml; p < 0.001). s t i m u l a t e d GH s e c r e t i o n i n o l d r a t s administered GHW o r GHRP was s i g n i f i c a n t l y lower t h a n i n young r a t a (393 * 69 ng/ml v e 1477 t 111 ng/ml; p < 0 . 0 1 ) , whereas plasma GH c o n c e n t r a t i o n s were comparable i n both age groups administered GHRH nnd CHRP (1079 t 106 ng/ml vs 1159 t 93 nglml).
Chronic coa d m i n i s t r a t i o n of GHRH and GHRP t o o l d r a t s a l s o r e s t o r e d youthful p a t t e r n s of GH s e c r e t i o n , increaeed p i t u i t a r y cH c o n c e n t r a t i o n s ( 7 + 2 pg/mg v s 51 i 9 pgjmg; p < 0.001) and increased serum IGP-1 (413 + 77 ng/ml v s 810 t 82 ng/ml).
These d a t a suggest t h a t blunted responses t o provocative CH r e l e a s i n g s t i m u l i r e s u l t from d e f e c t s i n p i t u i t a r y r e c e p t o r s , second messengers and/or t o inadequate p i t u i t a r y stimulation; each with d i f f e r e n t e f f e c t s on GH s e c r e t i o n . Receptor d e f e c t s completely blocked and second meseenger d e f e c t s p a r t i a l l y blocked GH s e c r e t o r y s t i m u l i , whereas inadequately stimulated p i t u i t a r i e s gave d i f f e r e n t i a l responses t o CH r e l e a s i n g peptides. Thus, by comparing responses t o lone and p a i r e d GH secretagogues it may be p o s s i b l e t o d i s c e r n t h e e t i o l o g y of GH s e c r e t o r y deficit^ i n c e r t a i n s h o r t s t a t u r e d c h i l d r e n . When CH s e c r e t o r y d e f i c i e n c y r e s u l t s from inadequate p i t u i t a r y s t r m u l a t i o n , c o -a d m i n i~t r a t i o n o f CH secretagogues may r e s t o r e proper CH s e c r e t i o n ae w e l l a s increaee p i t u i t a r y GH s t o r e s and serum ICF-1 concentratione. 13; CA 9.8y (4.7-11.2); HTSDS -2.5 i 0.51 wlth CDGA Increased HV from 5.0 i 1.1 cmiyr t o 7.1 i 0.8 cmlyr after 6 months a n d 8.6 1 1.4 cmlyr after 1 2 months of therapy. in s o m e chlldren however, rapld b o n e maturation compromised growth prognosis. Concentrations of OX (serum), epl-OX and other physlologicai steroid metabolltes (serum, urine) were measured by gaschromatography/mass-spectrometry In these children before a n d o n OX. Wlthln 2 4 h after OX, levels In serum varled between 8.7 a n d 0.4 nglml. Excretion of OX [epi-OX] In urine varied between 1 6 a n d 223 pg124h (x : 64.1 + 6 9 )~g/24h) [3.4 a n d 12.8 pgi24h (x = 5.9 t 3.6 pg124h)l . OX treatment s u p p r e s s e d androgen excretion [Androsteron from 536 1 4 9 8 before t o 370 i 192 pg124h o n OX; Etiocholanolon from 357 i 349 to 1 6 9 i 9 2 pg/24h]. Thls effect w a s m o r e pronounced In chlldren wlth prlmarlly hlgher androgen excretion.
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Conclusion : OX Is widely used, but knowledge of its action a n d metabollsm Is scarce. lndlvldual differences In metabolism a n d excretion may b e responsible for t h e side effects, e.g. rapid bone maturatlon. The Influence of OX o n t h e metabollsm of endogenous androgens lndlcates a n androgenic actlon of the substance. lndlvlduai d o s e adjustment a p p e a r s to b e necessary. GtlBP-related pcphdes in human serum, For tllis purpose polyclooal antiserd were raised in rabbits against panial sequences ol UIC extracellular domain of Ule Ilumarr GI1 receptor, which were selected on the basis ol scconda~y slmclurc calculalions suggesting their locauon on the surface of the molecule logelher will1 high llexibility Onc of Ule pcpt~dcs was finally chosen for cslablishing a RIA using lhls pcntadecapeptide for radiolabelling and for preparation of standuds. The spccific~ty of Ulc antisemm was cxamincd by FPLC s i~e exclusion chromatography (SEC) and Wcslem blotting (WB). In SEC. GHBP RIA activity coclukd wit11 Ule GH-binding activity a1 55 kDa will1 a lliinor pcak at 106 1Da. By WB. 2 bands at 54 and 73 kDa were visible. High concentralions of GH did no1 intcrlere in Ulc GHBP RIA. Results olGllBP n~easuremcnts wcre referred to the pept~dc standard md arc given as ngfnll pcpl~dc cquivdcnts. Results: Shon children will1 low IGF-I levels (<5111 pcrccnlilc. n=13. age 11.M2.3 yr) had significanlly decreased GHBP lcvcls as compared to short chldren with nornid IGF-I lcvcls (n=13. 12.212.3 yr) or an age-nlatched control group (n=26. 11.6t3.6 yr): (~nearaSD) 31f15 ng/~lll vcrsus 48113 nun11 or 46123 ng/ml resp. (p<0.05). Patients wit11 cllmnic rend Failure (CRF) with rcsidud glo~nemlar fil1r:llion (n=10, age l l.lf3.8 yr) had ~narkcdly dirllin~shcd GHBP lcvcls (I If4 ng/nll, p<O.WI). wllcreas patients with endstage rerut failure (ESRF: n=IO, 13.Of2.9 yr) showed a rcnlarkable intcrindivldual "arialion (37i35 ngfnil, range 4 -101 ngfnil). Conclusions: 1) Tlie resulls or RIA nleasurements conlparc quditalively well with functiond assays. 2) Low IGF-I levch in shan cluldren may be related to low GHBP (or GH receplor) levels. 3) Low GIIBP levels in uremic paticnts may be due lo impaired synthesis. 4) In exlrc~l~c cases of ESRF diminislicd GHBP SynUiesis may be counterbdanced by impaired clearance Icading to elcvalcd GHBP lcvcls. The lreatlnenl of shon children wiUiout GI1 deficiency (GHD) poses a major question: whether or not short-leml chmgcs of GtI-dependent paramcsrs could predicl h e long-lerm growth response lo GH treatment. For this pulpose, serum IGF-l and IGFBP-3 levels were studied in short prepubend children willrout "classical" GHD as defined by a peak GH level above 20 mU/L in Ilie argirune-insulin-tolermcc test (5 girls. 33 boys, age 8.9tL.9 yr) receiving 0.1 IU rhGH per kg body weight daily. llcigllt velocity (HV) was dclcrnined during a I-yr pretreatment pcriod and during Ule 1st (n=38) and 2nd (n=32) year of trcalment. IGF-I and IGFBP-3 wcre nlcasured by spccific RlAs at start of therapy (index 0) and after I month (~ndcx Iln). Resulls: HV (~iies~+SD) increased lrom 4.97f 1.01 cnllyr lo 7.6M0.99 alul 6.42i 1.24 clldyr during !he 1st and 2nd ycar rcsp. The I monU1 increase of IGF-I levels was lmm 131154 ppJ lo 199i90 pgll and of IGFBP-3 fro111 2.84i0.68 mg/l lo 3.57iO.90 n l u . The corrclallon coclficicnu and p-values bclwccn IGF-pam~eters (IGF-I,. AIGF-I= IGF-I,, -IGF-6. %IGF-I= IGF-I,,JIGF-I,. IGFBP-3 accordingly) and the increases of HV during lhc 1st (AIIV,) old 2nd ycar (AIIV,) are givcn below (r,(p)):
IGF-I, AIGF-I QIGF-I IGFBP-30 AIGFBP-3 QIGFBP-3 AHV, -.33(.0110) .13 (.1650 2) The predictive polential of the shon-tern increases of IGF-I and IGFBP-3 1s belter lor Ule 2nd year Ulan Ule 151 year. 3) IGFBP-3 is superior to IGF-I due to ils negligible circadian fluclualions during GH therapy.
